First clinical experience with Zr-89-Df-IAB22M2C PET/MRI in patients with metastatic cancer

被引：0
|
作者：
Schwenck, J. [1 ,2 ,3 ]
Sonanini, D. [2 ,4 ]
Seyfried, D. [2 ]
Ehrlichmann, W. [2 ]
Kienzle, G. [2 ]
Reischl, G. [2 ,3 ]
Wilson, I. [5 ]
Le, W. [5 ]
Smith, G. [5 ]
Korn, R. [5 ]
Seith, F. [6 ]
Forschner, A. [7 ]
Eigentler, T. [7 ]
Roecken, M. [3 ,7 ,8 ]
Zender, L. [3 ,4 ,8 ]
Pichler, B. [2 ,3 ,8 ]
Flatz, L. [7 ]
Kneilling, M. [2 ,3 ,7 ]
la Fougere, C. [1 ,3 ,8 ]
机构：
[1] Eberhard Karls Univ Tubingen, Dept Nucl Med & Clin Mol Imaging, Tubingen, Germany
[2] Eberhard Karls Univ Tubingen, Dept Preclin Imaging & Radiopharm, Werner Siemens Imaging Ctr, Tubingen, Germany
[3] Eberhard Karls Univ Tubingen, Cluster Excellence iFIT EXC 2180 Image Guided & F, Tubingen, Germany
[4] Eberhard Karls Univ Tubingen, Dept Med Oncol & Pneumol Internal Med 8, Tubingen, Germany
[5] ImaginAb Inc, Inglewood, CA USA
[6] Eberhard Karls Univ Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany
[7] Eberhard Karls Univ Tubingen, Dept Dermatol, Tubingen, Germany
[8] German Canc Res Ctr DKFZ Partner Site Tubingen, German Canc Consortium DKTK, Tubingen, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-0863
引用
收藏
页码：S303 / S304
页数：2
相关论文
共 50 条
  • [31] 89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
    Pandit-Taskar, Neeta
    O'Donoghue, Joseph A.
    Beylergil, Volkan
    Lyashchenko, Serge
    Ruan, Shutian
    Solomon, Stephen B.
    Durack, Jeremy C.
    Carrasquillo, Jorge A.
    Lefkowitz, Robert A.
    Gonen, Mithat
    Lewis, Jason S.
    Holland, Jason P.
    Cheal, Sarah M.
    Reuter, Victor E.
    Osborne, Joseph R.
    Loda, Massimo F.
    Smith-Jones, Peter M.
    Weber, Wolfgang A.
    Bander, Neil H.
    Scher, Howard I.
    Morris, Michael J.
    Larson, Steven M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (11) : 2093 - 2105
  • [32] 89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
    Neeta Pandit-Taskar
    Joseph A. O’Donoghue
    Volkan Beylergil
    Serge Lyashchenko
    Shutian Ruan
    Stephen B. Solomon
    Jeremy C. Durack
    Jorge A. Carrasquillo
    Robert A. Lefkowitz
    Mithat Gonen
    Jason S. Lewis
    Jason P. Holland
    Sarah M. Cheal
    Victor E. Reuter
    Joseph R. Osborne
    Massimo F. Loda
    Peter M. Smith-Jones
    Wolfgang A. Weber
    Neil H. Bander
    Howard I. Scher
    Michael J. Morris
    Steven M. Larson
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 2093 - 2105
  • [33] Monitoring intratumoral CD8 T cell infiltrates in human stem cell engrafted mice during single agent and combination immunotherapy with T cell bispecific antibodies using the human PET-tracer 89Zr-Df-IAB22M2C
    Griessinger, Christoph M.
    Mascioni, Alessandro
    Jia, Fang
    Torgov, Michael
    Nayak, Tapan
    Mohan, Preethi Latha Bhavani
    Nicolini, Valeria G.
    Sam, Johannes
    Claus, Christina
    Ferrara-Koller, Claudia
    Bacac, Marina
    Umana, Pablo
    Wilson, Ian
    Klein, Christian
    Tessier, Jean J.
    CANCER RESEARCH, 2019, 79 (13)
  • [34] Imaging of tumor infiltrating T cells with an anti-CD8 minibody (Mb) 89Zr-IAB22M2C, in advanced solid tumors.
    Postow, Michael A.
    Harding, James J.
    Hellmann, Matthew David
    Gordon, Michael S.
    Tsai, Frank
    Donoghue, Joseph A. O'
    Lewis, Jason Stuart
    Wu, Anna M.
    Le, William
    Korn, Ronald Lee
    Weber, Wolfgang
    Wolchok, Jedd D.
    Pandit-Taskar, Neeta
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] Pilot study of dual imaging with 89Zr-IAB2M and 68Ga-PSMA-11 PET/CT prior to prostatectomy.
    Niaz, Muhammad Junaid
    Jhanwar, Yuliya
    Flynn, Thomas
    Vallabhajosula, Shankar
    Khani, Francesca
    Robinson, Brian D.
    Tagawa, Scott T.
    Bander, Neil Harrison
    Scherr, Douglas
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [36] [89Zr]Zr-PSMA-617 PET/CT in biochemical recurrence of prostate cancer: first clinical experience from a pilot study including biodistribution and dose estimates
    Florian Rosar
    Andrea Schaefer-Schuler
    Mark Bartholomä
    Stephan Maus
    Sven Petto
    Caroline Burgard
    Bastiaan M. Privé
    Gerben M. Franssen
    Yvonne H. W. Derks
    James Nagarajah
    Fadi Khreish
    Samer Ezziddin
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 4736 - 4747
  • [37] [89Zr]Zr-PSMA-617 PET/CT in biochemical recurrence of prostate cancer: first clinical experience from a pilot study including biodistribution and dose estimates
    Rosar, Florian
    Schaefer-Schuler, Andrea
    Bartholomae, Mark
    Maus, Stephan
    Petto, Sven
    Burgard, Caroline
    Prive, Bastiaan M.
    Franssen, Gerben M.
    Derks, Yvonne H. W.
    Nagarajah, James
    Khreish, Fadi
    Ezziddin, Samer
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (13) : 4736 - 4747
  • [38] 89Zr-trastuzumab and 89Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients
    Gaykema, Sietske B. M.
    Schroder, Carolien P.
    Vitfell-Rasmussen, Joanna
    Chua, Sue
    Munnink, Thijs H. Oude
    Brouwers, Adrienne H.
    Bongaerts, Alfons H. H.
    Akimov, Mikhail
    Fernandez-Ibarra, Cristina
    Lub-de Hooge, Marjolijn N.
    de Vries, Elisabeth G. E.
    Swanton, Charles
    Banerji, Udai
    CLINICAL CANCER RESEARCH, 2014, 20 (15) : 3945 - 3954
  • [39] 89Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer
    Verhoeff, Sarah R.
    van de Donk, Pim P.
    Aarntzen, Erik H. J. G.
    Oosting, Sjoukje F.
    Brouwers, Adrienne H.
    Miedema, Iris H. C.
    Voortman, Jens
    van Oordt, Willemien C. Menke -van der Houven
    Boellaard, Ronald
    Vriens, Dennis
    Slingerland, Marije
    Hermsen, Rick
    van Engen-van Grunsven, Ilse
    Heskamp, Sandra
    van Herpen, Carla M. L.
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (10) : 1523 - 1530
  • [40] Imaging HER2-positive metastatic esophagogastric cancer with 89Zr-trastuzumab PET and 18F-FDG PET.
    Lumish, Melissa Amy
    Maron, Steven Brad
    Paroder, Viktoriya
    Philemond, Steven
    Donoghue, Joseph A. O'
    Schoder, Heiko
    Lewis, Jason Stuart
    Janjigian, Yelena Y.
    Pandit-Taskar, Neeta
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345